Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Parkinson's disease
Biotech
AbbVie-bound Cerevel reports phase 3 Parkinson's victory
The backing singer in AbbVie’s $8.7 billion takeover of Cerevel Therapeutics is having its moment in the spotlight.
Nick Paul Taylor
Apr 18, 2024 8:34am
Sage fails first of 4 tests for key prospect, exits Parkinson's
Apr 17, 2024 8:34am
BioVie cuts 'most de-risked program,' will seek partner
Mar 11, 2024 11:12am
Gain's clinical Parkinson's drug restores motor function in mice
Feb 6, 2024 8:00am
FDA approves Abbott’s smallest, longest-lasting DBS implant
Jan 25, 2024 11:57am
Annovis blames ‘data cleaning’ for ph. 3 Parkinson’s data delays
Jan 24, 2024 8:59am